BDO Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-26
Closed 667
2019
Q1
$0 Hold
26
﹤0.01% 644
2018
Q4
$0 Hold
26
﹤0.01% 600
2018
Q3
$1K Hold
26
﹤0.01% 602
2018
Q2
$1K Buy
+26
New +$630 ﹤0.01% 623

Other funds holding NTLA

BDO Wealth Advisors's NTLA Position: Q2 2019 in Review

BDO Wealth Advisors sold out of Intellia Therapeutics (NTLA) in Q2 2019, closing a stake of 26 shares.

BDO Wealth Advisors first reported a position in NTLA in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q3 2018. 144 funds tracked by Wall St. Rank hold NTLA as of Q2 2019.

  • BDO Wealth Advisors reported no remaining Intellia Therapeutics position as of Q2 2019 after selling out during the quarter.
  • BDO Wealth Advisors sold 26 Intellia Therapeutics shares in Q2 2019.
  • BDO Wealth Advisors first reported a position in Intellia Therapeutics in Q2 2018 and held it in 4 quarters.
  • BDO Wealth Advisors's Intellia Therapeutics position peaked at $1K in Q3 2018.
  • 144 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2019.

Based on BDO Wealth Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.